Skip to main content
Caplight Logo









K-MedLinker

K-MedLinker

Private
SeoulHealthcare & Life Scienceshttps://www.k-medlinker.com/

Last Round

Series E

Dec 1, 2020

Est. Valuation

$3.93B

Total Funding Raised

$761.89M

Company Overview

K-MedLinker is a medical tourism company that provides end-to-end coordination services for international patients seeking medical care in South Korea, including hospital matching, travel logistics, and interpretation.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Fashion & Beauty, Compliance

Business Model

B2C

Customer Profile

Marketplace Commission, Services & Consulting

AI Layer

Non-AI

Keywords

medical tourismmedical conciergemedical travel agencyplastic surgery tourismk-beauty tourismmedical tourism facilitatorhospital matchingmedical interpretationhealth checkupmedical visa supportelective surgerypatient coordinationmedical travel logistics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

K-MedLinker Comparables

Compare K-MedLinker with similar companies based on industry and business-model similarity.

K-MedLinker comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Docfinderkorea
84%
Medical Avenue Co., Ltd.
81%
Jivaka Care
80%

K-MedLinker Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series EDec 1, 2020
Series DJun 1, 2018
Series CDec 6, 2017
Series BSep 7, 2015
Series AFeb 1, 2015
Angel
Aug 12, 2014

K-MedLinker Investors

Notable investors and investment history

K-MedLinker investors
InvestorRounds
PreAngelAngel
Ceyuan VenturesAngel
Yunfeng CapitalSeries B
HongShan Capital Group (HSG)Series D, Series C, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2020

    $514M round led by Sino Biopharmaceutical Limited.

  • Dec 6, 2017

    Raised $60M with participation from Tencent and HongShan Capital Group.

K-MedLinker Filings

Explore SEC and related filing metadata, where available.

K-MedLinker filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about K-MedLinker's valuation, stock price, and market status.

Is K-MedLinker a public or private company?

K-MedLinker is a private company.

What is the current stock price of K-MedLinker?

K-MedLinker is a private company with no public stock price. Caplight tracks K-MedLinker's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is K-MedLinker worth (valuation)?

K-MedLinker's valuation is estimated at $3.9B based on funding round data.

Can I buy K-MedLinker stock?

K-MedLinker shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was K-MedLinker's last funding round?

K-MedLinker's most recent funding round was Series E on December 1, 2020.

Who are the main investors in K-MedLinker?

Key investors in K-MedLinker include HongShan Capital Group (HSG).

Will K-MedLinker IPO soon?

No public IPO plans have been announced for K-MedLinker.

How can I track K-MedLinker secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor K-MedLinker's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range1
Year Founded2025
Last FundingDec 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?